Replication block by an enediyne drug-DNA deoxyribose adduct.
Under anaerobic conditions neocarzinostatin chromophore, an enediyne antibiotic, forms a covalent drug-DNA adduct on the 5' carbon of deoxyribose at a specific single site in a 2-nucleotide bulge, rather than strand cleavage, by a mechanism involving general base-catalyzed intramolecular drug activation to a reactive radical species. We have taken advantage of the selectivity of this reaction to prepare a single-stranded oligonucleotide containing a single drug adduct at a T residue and to study its effect on the template properties of the oligonucleotide in replicative synthesis, as followed by 5'-32P-labeled primer extension by several DNA polymerases. With the Klenow fragment of Escherichia coli DNA polymerase I, synthesis stops at the base immediately 3' to the adduct. The same enzyme, but lacking 3' to 5' exonuclease activity, permits synthesis to proceed by one additional nucleotide. This effect is enhanced when Mn2+ is substituted for Mg2+. T4, herpes simplex virus, and cytomegalovirus DNA polymerases all act like Klenow polymerase. Sequenase (exo-minus T7 DNA polymerase) is qualitatively similar to exo-minus Klenow polymerase but is more efficient in inserting a nucleotide opposite the lesion. With the small-gap-filling human DNA polymerase beta, which lacks intrinsic exonucleolytic activity, primer extension proceeds to the nucleotide opposite the lesion. However, when a gap was created opposite the lesion, polymerase beta adds as many as two additional nucleotides 5' to the adduct site. The fidelity of base incorporation opposite the lesion was not impaired, in contrast with adducts on DNA bases.
Kappen
L S
LS
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Goldberg
I H
IH
D000903:Antibiotics, Antineoplastic / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D017122:Bacteriophage T4 / Q000201:enzymology; D017123:Bacteriophage T7 / Q000201:enzymology; D020137:Base Pair Mismatch / Q000187:drug effects; D001483:Base Sequence; D004247:DNA / Q000037:antagonists & inhibitors* / Q000096:biosynthesis*; D018736:DNA Adducts / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D004256:DNA Polymerase I / Q000037:antagonists & inhibitors; D004259:DNA-Directed DNA Polymerase; D003855:Deoxyribose / Q000737:chemistry* / Q000494:pharmacology; D053281:Enediynes; D019384:Nucleic Acid Synthesis Inhibitors; D013698:Templates, Genetic; D014764:Viral Proteins / Q000037:antagonists & inhibitors; D009353:Zinostatin / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology
D000903:Antibiotics, Antineoplastic; D018736:DNA Adducts; D053281:Enediynes; D019384:Nucleic Acid Synthesis Inhibitors; D014764:Viral Proteins; C069983:gene 43 protein, Enterobacteria phage T4; D003855:Deoxyribose; C032372:neocarzinostatin chromophore; D004247:DNA; D009353:Zinostatin; C034970:bacteriophage T7 induced DNA polymerase; D004256:DNA Polymerase I; D004259:DNA-Directed DNA Polymerase